Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor Overview

October 2016 Corporate Presentation

2015 Annual Report

  • Corporate Profile

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
    Read more

    Stock chart for: SBPH.O.  Currently trading at $7.90 with a 52 week high of $13.25 and a 52 week low of $7.14.
    12/07/164:00 p.m. ET
  • Upcoming Events

    There are currently no events scheduled.

Latest News

Data provided by Nasdaq. Minimum 15 minutes delayed.